Jméno

Michael Kubbutat, Ph.D.

Instituce ProQinase GmbH
Pozice Head R&D, ProQinase GmbH
Adresa ProQinase GmbH
Breisacher Str. 117
D-79106 Freiburg
Germany
Kontaktní email
Osobní web
Popis
Michael Kubbutat obtained his PhD in Biology at the Medical University of Luebeck, Germany, where he studied the function of the proliferation marker Ki-67 in tumor cells. He started his postdoctoral fellowship at the Ludwig Institute for Cancer Research in London, UK, and continued it at the National Cancer Institute, Frederick, USA. During his postdoctoral fellowship he investigated the role of the tumor suppressor protein p53, and identified the oncoprotein mdm2 as major regulator of p53 protein stability. In 1999 he joined the Tumor Biology Center Freiburg, Germany as group leader, and since 2001 he is Head of Research Development at ProQinase GmbH, a subsidiary of the Tumor Biology Center Freiburg, where the focus of his work is on the discovery and pre clinical development of protein kinase inhibitors in oncology.
Oblasti zájmu
  • Molekulární terapeutické cíle
  • Molekulární biologie
Videa
Přednášející: Michael Kubbutat, Ph.D.
Hodnocení:
Počet hodnotících: 0
Počet zobrazení: 245
Přidej na TiskPřidej na OblíbenéPřidej na e-mailPřidej na FacebookPřidej na Twitter
 
0.32s